Browsing Tag
Pharma business news
24 posts
Biogen strikes $600m deal with Pfizer for promising schizophrenia drug
Biogen, a leading US biotechnology firm, has reached a significant agreement to acquire Pfizer’s neurology drug candidate, PF-04958242,…
March 12, 2018
Merck to acquire Australian biotech firm Viralytics for $394m to bolster oncolytic immunotherapy treatments
Significant Acquisition in Pharma Industry: US pharmaceutical giant Merck has announced a definitive agreement to acquire Viralytics, an…
February 22, 2018
Roche set to fully acquire Flatiron Health in $1.9bn deal to accelerate cancer drug development
Roche, the Swiss pharmaceutical giant, has announced its plans to fully acquire Flatiron Health, a leading oncology software…
February 16, 2018
Seattle Genetics to acquire Cascadian Therapeutics for $614m to bolster oncology portfolio
Seattle Genetics, a leader in oncology biotechnology, has announced the acquisition of Cascadian Therapeutics for approximately $614 million,…
February 3, 2018
Sanofi to acquire Belgian biotech firm Ablynx for €3.9bn in all-cash deal
French pharmaceutical giant Sanofi has successfully finalized an agreement to acquire Ablynx, a Belgian biotechnology firm, for approximately…
January 30, 2018
Sanofi to acquire Bioverativ for $11.6bn to expand into rare blood disorders
Sanofi has announced a definitive agreement to acquire Bioverativ, a US biotechnology company specializing in the treatment of…
January 22, 2018
Takeda Pharmaceutical set to acquire TiGenix for €520m, enhancing gastroenterology and specialty care offerings
Japanese pharmaceutical giant Takeda Pharmaceutical has announced a proposal to acquire TiGenix, a Belgium-based cell therapy company, for…
January 8, 2018
Mallinckrodt to acquire Sucampo Pharmaceuticals in $1.2bn deal
In a strategic move to broaden its pharmaceutical offerings, UK-based Mallinckrodt has announced the acquisition of Sucampo Pharmaceuticals,…
December 26, 2017
Roche to acquire Ignyta for $1.7bn to enhance oncology portfolio
Roche Pharmaceuticals, a prominent Swiss pharmaceutical company, has entered into a definitive merger agreement to acquire Ignyta, a…
December 22, 2017
Teva Pharmaceutical announces major global restructuring with 14,000 job cuts
Teva Pharmaceutical Industries, the Israel-based generic drug manufacturer, has unveiled a drastic two-year restructuring plan aimed at rejuvenating…
December 16, 2017